Bibliography
- Naz SM, Symmons DPM. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871-83
- Chakravarty EF, Genovese MC. Associations between rheumatoid arthritis and malignancy. Rheum Dis Clin North Am 2004;30:271-84
- Bernatsky S, Clarke A, Suissa S. Lung cancer after exposure to disease modifying anti-rheumatic drugs. Lung cancer 2008;59:266-9
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96
- Coory M, Baade P, Aitken J, et al. Trends for in situ and invasive melanoma in Queensland Australia, 1982 – 2002. Cancer Causes Control 2006;17:21-7
- Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975 – 2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;110:2119-52
- Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century. Part 1. Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007;82:364-80
- Fortes C, de Vries E. Nonsolar occupational risk factors for cutaneous melanoma. Int J Dermatol 2008;47:319-28
- Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992 – 2003. Ann Intern Med 2008;148:728-36
- Hollenbeak CS, Todd MM, Billingsley EM, et al. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005;104:1962-7
- Webster AC, Craig JC, Simpson JM, et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15, 183 recipients. Am J Transplant 2007;7:2140-51
- Le Mire L, Hollowood K, Gray D. Melanomas in renal transplant recipients. Br J Dermatol 2006;154:472-7
- Katusic S, Beard CM, Kurland LT, et al. Occurrence of malignant neoplasms in the Rochester, Minnestota Rheumatoid Arthritis Cohort. Am J Med 1985;78:50-5
- Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11
- Mellemkjær L, Linet MS, Gridley G, et al. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996;32A:1753-7
- Thomas E, Brewster DH, Black RJ, MacFarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000;88:497-502
- Askling J, Fored CM, Brandt L, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumor necrosis factor antagonists. Ann Rheum Dis 2005;64:1421-6
- Setoguchi S, Soloman DH, Weinblatt ME, et al. Tumor necrosis factor a antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2757-64
- Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95
- Buchbinder R, Barber M, Heuzenroeder L, et al. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 2008;59:794-9
- Hemminki K, Li X, Sundquist K, et al. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford) 2008;47:698-701
- Abasolo L, Judez E, Descalzo MA, et al. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum 2008;37:388-97
- Jeannou J, Goupille P, Valat JP. Association of methotrexate, rheumatoid arthritis, and melanoma in 2 patients [letter]. J Rheumatol 1997;24:1444-5
- Potter T, Hardwick N, Mulherin D. Multiple malignant melanomas in a patient with RA treated with methotrexate [letter]. J Rheumatol 1998;25:2282-3
- Bologna C, Picot MC, Jorgensen C, et al. Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis 1997;56:97-102
- Fulcherio GJ, Salvaggio H, Drabick JJ, et al. Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies. J Am Acad Dermatol 2007;56:S65-7
- Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA 2006;295:2275-85
- Edwards JCW, Szczepaniski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81
- Cohen SB, Emery P, Greenwald GW, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum 2006;54:2793-806
- Kremer JM, Genant HK, Moreland LW, et al. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis. Ann Int Med 2006;144:865-76
- Chuang TY, Popescu A, Su WP, Chute CG. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-7
- Reizner GT, Chuang TY, Elpern DJ, et al. Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States. J Am Acad Dermatol 1993;29(2 Pt 1):184-9
- Staples MP, Elwood M, Burton RC, et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006;184:6-10
- Chuang TY, Popescu NA, Su WP, Chute CG. Squamous cell carcinoma. A population-based incidence study in Rochester, Minn. Arch Dermatol 1990;126:185-8
- Chuang TY, Reizner GT, Elpern DJ, et al. Squamous cell carcinoma in Kauai, Hawaii. Int J Dermatol 1995;34:393-7
- Wei Q, Matanoski GM, Farmer ER, et al. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci USA 1993;90:1614-8
- Freidman GD, Tekawa IS. Association of basal cell skin cancers with other cancers (United States). Cancer Causes Control 2000;11:891-7
- Efird JT, Friedman GD, Habel L, et al. Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol 2002;12:469-75
- Lupi O. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma. Int J Dermatol 2007;46:1113-7
- Asgari MM, Kiviat NB, Critchlow CW, et al. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 2008;128:1409-17
- Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC. Beta-papillomavirus infection and skin cancer. J Invest Dermatol 2008;128:1355-8
- Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001;63:8-18
- Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 2008;58(5 Suppl 2):S129-32
- Euvard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-91
- Ho WL, Murphy GM. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients. Br J Dermatol 2008;158:217-24
- Crespo-Leiro MG, Alonso-Pulpon L, Vazquez de Prada JA, et al. Malignancy after heart transplantation: incidence, prognosis, and risk factors. Am J Transplant 2008;8:1031-9
- Vasudev B, Hariharan S. Cancer after renal transplantation. Curr Opin Nephrol Hypertens 2007;16:523-8
- Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985 – 1998. Br J Cancer 2003;89:94-100
- Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum 1997;40(9):1580-6
- Chakravarty ER, Michaud K, Wolfe F. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 2005;32:2130-5
- Dixon W, Silman A. Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and infection? Arthritis Res Ther 2006;8:111-3
- Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81
- Smith KJ, Skelton HG. Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor receptor IgG1-Fx fusion complex therapy. J Am Acad Dermatol 2001;45:953-6
- Esser AC, Abril A, Fayne S, Doyle JA. Acute development of multiple keratocanthomas and squamous cell carcinomas after treatment with infliximab. J Am Acad Dermatol 2004;50(Suppl 5):S75-7
- Weinblatt M, Combe B, Covucci A, et al. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and non-biologic disease modifying antirheumatic drugs. Arthritis Rheum 2006;54:2807-16
- Kremer JM, Dougados M, Emery P, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept. Arthritis Rheum 2005;52:2263-71
- Miyazaki T, Fujimaki K, Shirasugi Y, et al. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection. Am J Hematol 2007;82:1106-9